Bartlett & Co’s Vaxart VXRT Stock Holding History

Bartlett & Co’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$0	Hold	200	–	–	﹤0.01%	1256
2023 Q3	$0	Hold	200	–	–	﹤0.01%	1187
2023 Q2	$0	Hold	200	–	–	﹤0.01%	1172
2023 Q1	$0	Hold	200	–	–	﹤0.01%	1102
2022 Q4	$0	Hold	200	–	–	﹤0.01%	1182
2022 Q3	$0	Hold	200	–	–	﹤0.01%	1277
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	1253
2022 Q1	$1K	Buy	+200	New	+$1.01K	﹤0.01%	1040
2021 Q4	–	Sell	-200	Closed	-$2K	–	880
2021 Q3	$2K	Hold	200	–	–	﹤0.01%	894
2021 Q2	$1K	Hold	200	–	–	﹤0.01%	962
2021 Q1	$1K	Buy	+200	New	+$1.54K	﹤0.01%	989

Other funds holding VXRT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Bartlett & Co's VXRT Position: Q4 2023 in Review

Bartlett & Co held its Vaxart (VXRT) position steady in Q4 2023 at 200 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Bartlett & Co first reported a position in VXRT in Q1 2021 and has held it in 11 quarters since. The position peaked at $2K in Q3 2021. 87 funds tracked by Wall St. Rank hold VXRT as of Q4 2023.

Bartlett & Co held 200 shares of Vaxart worth $0 as of Q4 2023.
Bartlett & Co left its Vaxart share count unchanged in Q4 2023.
Vaxart made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1256 holding.
Bartlett & Co first reported a position in Vaxart in Q1 2021 and has held it in 11 quarters since.
Bartlett & Co's Vaxart position peaked at $2K in Q3 2021.
87 funds tracked by Wall St. Rank held Vaxart as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.